Related Experiment Video
Updated: May 29, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
Integrin-linked kinase in gastric cancer cell attachment, invasion and tumor growth
Gang Zhao1, Li-Li Guo, Jing-Yong Xu
1Department of General Surgery, Beijing Hospital, Peking University, 100730 Beijing, China.
Aim:
To investigate the effects of integrin-linked kinase (ILK) on gastric cancer cells both in vitro and in vivo.
Methods:
ILK small interfering RNA (siRNA) was transfected into human gastric cancer BGC-823 cells and ILK expression was monitored by real-time quantitative polymerase chain reaction, Western blotting analysis and immunocytochemistry. Cell attachment, proliferation, invasion, microfilament dynamics and the secretion of vascular endothelial growth factor (VEGF) were also measured. Gastric cancer cells treated with ILK siRNA were subcutaneously transplanted into nude mice and tumor growth was assessed.
Results:
Both ILK mRNA and protein levels were significantly down-regulated by ILK siRNA in human gastric cancer cells. This significantly inhibited cell attachment, proliferation and invasion. The knockdown of ILK also disturbed F-actin assembly and reduced VEGF secretion in conditioned medium by 40% (P < 0.05). Four weeks after injection of ILK siRNA-transfected gastric cancer cells into nude mice, tumor volume and weight were significantly reduced compared with that of tumors induced by cells treated with non-silencing siRNA or by untreated cells (P < 0.05).
Conclusion:
Targeting ILK with siRNA suppresses the growth of gastric cancer cells both in vitro and in vivo. ILK plays an important role in gastric cancer progression.
Insights
Targeting integrin-linked kinase (ILK) with small interfering RNA (siRNA) effectively suppressed gastric cancer cell growth. This study demonstrates ILK
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Integrin-linked kinase (ILK) is implicated in various cellular processes.
- Gastric cancer progression involves complex molecular mechanisms.
- Understanding ILK's role is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the role of integrin-linked kinase (ILK) in gastric cancer.
- To evaluate the therapeutic potential of targeting ILK in gastric cancer models.
Main Methods:
- Utilized small interfering RNA (siRNA) to down-regulate ILK expression in human gastric cancer cells (BGC-823).
- Assessed ILK expression via real-time quantitative PCR, Western blotting, and immunocytochemistry.
- Evaluated effects on cell attachment, proliferation, invasion, F-actin dynamics, and vascular endothelial growth factor (VEGF) secretion.
- Investigated tumor growth in vivo using a xenograft mouse model.
Main Results:
- ILK siRNA significantly reduced ILK mRNA and protein levels in gastric cancer cells.
- Knockdown of ILK inhibited cell attachment, proliferation, and invasion.
- ILK inhibition disrupted F-actin assembly and decreased VEGF secretion by 40%.
- Tumor growth, volume, and weight were significantly reduced in vivo after ILK siRNA treatment.
Conclusions:
- Targeting ILK with siRNA effectively suppresses gastric cancer cell growth both in vitro and in vivo.
- ILK plays a critical role in the progression of gastric cancer.
- ILK represents a potential therapeutic target for gastric cancer treatment.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Cancer Cell Migration through Invadopodia
Selectins
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

